CAPR Shares Outstanding History
Below is a table of the CAPR shares outstanding history going back to 11/21/2013:

Date CAPR Shares Outstanding
11/21/201387041
3/26/20141.17M
5/12/20141.17M
8/12/20141.17M
11/12/20141.17M
3/9/20151.62M
3/13/20151.62M
5/11/20151.62M
8/12/20151.63M
11/12/20151.63M
3/29/20161.80M
5/12/20161.80M
8/12/20161.80M
11/11/20162.14M
3/14/20172.14M
5/12/20172.26M
8/10/20172.35M
11/10/20172.57M
3/20/20182.77M
5/10/20182.91M
8/9/20183.07M
11/14/20183.11M
3/28/20193.37M
5/13/20193.47M
6/5/20193.47M
8/7/20193.74M
11/8/20194.25M
3/27/20208.91M
5/13/202014.26M
8/7/202019.72M
11/12/202020.45M
3/12/202122.80M
5/13/202122.88M

Also see: CAPR Market Cap History
CAPR YTD Return
CAPR Historical Shares Outstanding:
+110.68% CAGR
CAPR Historical Shares Outstanding: +110.68% CAGR

Mouse over chart for data details
11/21/2013 ...5/13/2021
Capricor Therapeutics is a clinical-stage biotechnology company focused on the discovery, development and commercialization of biological therapies for the treatment of diseases, with a focus on Duchenne muscular dystrophy (DMD), and other rare disorders. Co. is conducting HOPE-2, a Phase II clinical trial in the United States with its product candidate, CAP-1002, a cardiac cell derived therapy which is being used to treat patients with late-stage DMD. Additionally, Co. is developing its exosomes platform technology as a vaccine and therapeutic investigating a variety of disorders. Exosomes act as messengers to regulate the functions of neighboring or distant cells. We show 33 historical shares outstanding datapoints in our coverage of CAPR's shares outstanding history.

Understanding the changing numbers of CAPR shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like CAPR versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching CAPR by allowing them to research CAPR shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes
Get Free SEC filing alerts for CAPR:
CAPR SEC Filing Email Alerts ServiceExternal link
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Capricor Therapeutics (CAPR) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

CARA Shares Outstanding History
CASI Shares Outstanding History
CASM Shares Outstanding History
CATB Shares Outstanding History
CATS Shares Outstanding History
CBAY Shares Outstanding History
CBIO Shares Outstanding History
CBLI Shares Outstanding History
CBM Shares Outstanding History
CBMG Shares Outstanding History
More Healthcare companies »

 

CAPR Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2021, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.